Delivery Order SPE2DB20D1100-SPE2DB24FB4C4

Award Date 4/22/24
Potential Completion Date 4/23/24
Potential Value $8.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,564,184,275 units of the pharmaceutical product MYRBETRIQ ER 50 MG TABLET 90S. The $28,014.79 delivery order was issued under an indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp as the prime contractor, which has a potential value of $999,999,999.00 and a performance period through...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $1,841.66 to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the supply of MYRBETRIQ ER 25 MG TABLET 30S, a pharmaceutical product, and does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is a part of a larger indefinite delivery...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of MYRBETRIQ ER 25 MG TABLET 90S. The contract has a potential value of $5,415.47 and a completion date of February 14, 2024. Amerisourcebergen Drug Corp is the prime contractor and has not received any set-aside designations for this award. This delivery order contract is part of a larger indefinite delivery...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $3,969.16 contract is for the supply of MYRBETRIQ ER 50 MG TABLET 90S, a specialty pharmaceutical product. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4,563,981,953 units of the pharmaceutical product MYRBETRIQ ER 25 MG Tablet 90S. The contract has a ceiling value of $10,218.10 and a performance period ending on March 18, 2024. Amerisourcebergen Drug Corp is also the prime contractor on a larger $999,999,999.00 indefinite delivery contract (IDC)...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of MYRBETRIQ ER 25 MG TABLET 90S. The contract has a potential value of $5,401.32 and a completion date of March 8, 2024. Amerisourcebergen Drug Corp is the prime contractor, and there are no set-aside designations indicated for this award. In addition to this delivery order, Amerisourcebergen Drug...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to supply 4564028065 - MYRBETRIQ ER 25 MG TABLET 90S. The $1,767.98 contract has a performance period through March 21, 2024 and does not have any set-aside designation. AmerisourceBergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) valued up to $999,999,999.00 awarded by DLA with a performance...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a Delivery Order (SPE2DX22FSZCW) valued at $39,654.32 to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation. This Firm Fixed Price contract is for the supply of 4557961228 - MYRBETRIQ ER 50 MG TABLET 90S. The contract does not have a set-aside designation and is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4563956659 MYRBETRIQ ER 50 MG TABLET 90S. The $16,636.96 contract has a performance period through March 14, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor for this order, which is issued under a larger $999,999,999.00 indefinite delivery...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide the pharmaceutical product MYRBETRIQ ER 25 MG TABLET 30S. The award, valued at $12,556.25, has an ultimate completion date of April 9, 2024. AmerisourceBergen Drug Corp is the prime contractor on an Indefinite Delivery Contract (IDC) with DLA valued up to $999,999,999.00 through December 31, 2025, which serves as...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FB4C4
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract valued at $8,135.26 to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of MYRBETRIQ ER 25 MG TABLET 90S. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, which has a total potential value of up to $999,999,999.00 and runs through December 31, 2025. Under this IDC, Amerisourcebergen provides a wide range of pharmaceutical products and medical supplies to support the Department of Defense's (DoD) military treatment programs and facilities globally. The contract does not have a set-aside designation. As a major pharmaceutical distribution company, Amerisourcebergen leverages its extensive supply chain network to efficiently fulfill government medical requirements.

Generated 7/22/24, 9:35 AM